Literature DB >> 17551931

First-event or marginal estimation of cause-specific hazards for analysing correlated multivariate failure-time data?

Bee-Choo Tai1, Bianca L De Stavola, Victor de Gruttola, Val Gebski, David Machin.   

Abstract

In the analysis of multivariate failure-time data, the effect of a treatment or an exposure on the hazard of each failure type is sometimes evaluated using only the information on the first event that occurs in every individual, ignoring all events that follow. A Cox proportional hazards model may be fitted to such data, yielding a cause-specific hazard ratio (HR) estimate of the exposure for each failure type conditional on surviving all other failure types. However, such an estimate would not fully utilize all the available information on event times. Alternatively, a marginal approach may be implemented to model the time distribution of each failure type beyond the subject's first failure to (any) second and later failures. We investigate the performance of these two approaches by simulating positive and negative correlated event times from exponential distributions. Surprisingly, our results suggest that the first-event-only method (when multiple failures are possible) performs as well as the marginal method in most practical situations. Generally, for a modest sample size of 400, it is possible to achieve at least 85 per cent coverage of the true marginal HR with the first-event method. Although the coverage is poor for a correlation of 0.7 and beyond, such a high correlation between competing event times may be biologically rather implausible.

Mesh:

Year:  2008        PMID: 17551931     DOI: 10.1002/sim.2944

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Separate and combined analysis of successive dependent outcomes after breast-conservation surgery: recurrence, metastases, second cancer and death.

Authors:  Virginie Rondeau; Simone Mathoulin-Pélissier; Lucie Tanneau; Annie J Sasco; Gaétan Macgrogan; Marc Debled
Journal:  BMC Cancer       Date:  2010-12-31       Impact factor: 4.430

2.  Analysis and design of randomised clinical trials involving competing risks endpoints.

Authors:  Bee-Choo Tai; Joseph Wee; David Machin
Journal:  Trials       Date:  2011-05-19       Impact factor: 2.279

3.  Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study.

Authors:  Sameer Parpia; Lehana Thabane; Jim A Julian; Timothy J Whelan; Mark N Levine
Journal:  BMC Med Res Methodol       Date:  2013-03-21       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.